Wallyn et al., 2019 - Google Patents
Synthesis, principles, and properties of magnetite nanoparticles for in vivo imaging applications—A reviewWallyn et al., 2019
View HTML- Document ID
- 12608394660719341095
- Author
- Wallyn J
- Anton N
- Vandamme T
- Publication year
- Publication venue
- Pharmaceutics
External Links
Snippet
The current nanotechnology era is marked by the emergence of various magnetic inorganic nanometer-sized colloidal particles. These have been extensively applied and hold an immense potential in biomedical applications including, for example, cancer therapy, drug …
- 238000003786 synthesis reaction 0 title abstract description 73
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wallyn et al. | Synthesis, principles, and properties of magnetite nanoparticles for in vivo imaging applications—A review | |
| Ansari et al. | Magnetic iron oxide nanoparticles: synthesis, characterization and functionalization for biomedical applications in the central nervous system | |
| Ganapathe et al. | Magnetite (Fe3O4) nanoparticles in biomedical application: From synthesis to surface functionalisation | |
| Ajinkya et al. | Magnetic iron oxide nanoparticle (IONP) synthesis to applications: present and future | |
| Nguyen et al. | Fe3O4 nanoparticles: structures, synthesis, magnetic properties, surface functionalization, and emerging applications | |
| Andrade et al. | Shape anisotropic iron oxide-based magnetic nanoparticles: Synthesis and biomedical applications | |
| Nguyen et al. | Iron oxide and gold based magneto-plasmonic nanostructures for medical applications: A review | |
| Salvador et al. | Microemulsion synthesis of superparamagnetic nanoparticles for bioapplications | |
| Ferreira et al. | The role of magnetic nanoparticles in cancer nanotheranostics | |
| Alromi et al. | Emerging application of magnetic nanoparticles for diagnosis and treatment of cancer | |
| Kim et al. | Synthesis and characterization of multifunctional chitosan-MnFe2O4 nanoparticles for magnetic hyperthermia and drug delivery | |
| Stafford et al. | Multimodal magnetic-plasmonic nanoparticles for biomedical applications | |
| Mittal et al. | Magnetic nanoparticles: An overview for biomedical applications | |
| Mokhosi et al. | Advances in the synthesis and application of magnetic ferrite nanoparticles for cancer therapy | |
| Mahdavi et al. | Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications | |
| Issa et al. | Magnetic nanoparticles: surface effects and properties related to biomedicine applications | |
| Fernández-Barahona et al. | Microwave-driven synthesis of iron-oxide nanoparticles for molecular imaging | |
| Kalubowilage et al. | Magnetic nanomaterials for magnetically-aided drug delivery and hyperthermia | |
| Khizar et al. | Aminodextran coated CoFe2O4 nanoparticles for combined magnetic resonance imaging and hyperthermia | |
| Razzaque et al. | Design and utility of metal/metal oxide nanoparticles mediated by thioether end-functionalized polymeric ligands | |
| Tarkistani et al. | Recent advances in the use of iron–gold hybrid nanoparticles for biomedical applications | |
| Ramnandan et al. | Chitosan, Polyethylene glycol and Polyvinyl alcohol modified MgFe2O4 ferrite magnetic nanoparticles in Doxorubicin delivery: A comparative study in vitro | |
| Belyanina et al. | Targeted magnetic nanotheranostics of cancer | |
| Baabu et al. | Iron oxide nanoparticles: a review on the province of its compounds, properties and biological applications | |
| Bonvin et al. | Tuning properties of iron oxide nanoparticles in aqueous synthesis without ligands to improve MRI relaxivity and SAR |